{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T12:30:00Z","timestamp":1794400200938,"version":"4.9.0"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T00:00:00Z","timestamp":1674000000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T00:00:00Z","timestamp":1674000000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Australian Government Research Training Program Scholarships"},{"name":"UTS Research Excellence"},{"name":"International Research Scholarship"},{"name":"UTS President Scholarship"},{"name":"Faculty of Science Seed Funding"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Preeclampsia is a pregnancy-specific cardiovascular disorder, involving significant maternal endothelial dysfunction. Although inappropriate placentation due to aberrant angiogenesis, inflammation and shallow trophoblast invasion are the root causes of preeclampsia, pathogenic mechanisms are poorly understood, particularly in early pregnancy. Here, we first confirm the abnormal expression of important vascular and inflammatory proteins, FK506-binding protein-like (FKBPL) and galectin-3 (Gal-3), in human plasma and placental tissues from women with preeclampsia\u00a0and\u00a0normotensive controls. We then employ a three-dimensional microfluidic placental model incorporating human umbilical vein endothelial cells (HUVECs) and a first trimester trophoblast cell line (ACH-3P) to investigate FKBPL and Gal-3 signaling in inflammatory conditions. In human samples, both circulating (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200917 controls;\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200930 preeclampsia) and placental (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009\u2265\u20096) FKBPL and Gal-3 levels were increased in preeclampsia compared to controls (plasma: FKBPL,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.0001; Gal-3,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.01; placenta: FKBPL,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.05; Gal-3,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.01), indicative of vascular dysfunction in preeclampsia. In our placenta-on-a-chip model, we show that endothelial cells are critical for trophoblast-mediated migration and that trophoblasts effectively remodel endothelial vascular networks. Inflammatory cytokine tumour necrosis factor-\u03b1 (10\u00a0ng\/mL) modulates both FKBPL and Gal-3 signaling in conjunction with trophoblast migration and impairs vascular network formation (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.005). Our placenta-on-a-chip recapitulates aspects of inappropriate placental development and vascular dysfunction in preeclampsia.\n                  <\/jats:p>","DOI":"10.1007\/s00018-022-04648-w","type":"journal-article","created":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T03:03:58Z","timestamp":1674011038000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["A placenta-on-a-chip model to determine the regulation of FKBPL and galectin-3 in preeclampsia"],"prefix":"10.1007","volume":"80","author":[{"given":"Sahar Masoumeh","family":"Ghorbanpour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Richards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dillan","family":"Pienaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Sesperez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamidreza","family":"Aboulkheyr Es.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina N.","family":"Nikolic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasa","family":"Karadzov Orlic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeljko","family":"Mikovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milan","family":"Stefanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoran","family":"Cakic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelrahim","family":"Alqudah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Gorrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine","family":"McGrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary M.","family":"Kavurma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Ebrahimi Warkiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4911-1014","authenticated-orcid":false,"given":"Lana","family":"McClements","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,18]]},"reference":[{"key":"4648_CR1","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/S0140-6736(10)60279-6","volume":"376","author":"EA Steegers","year":"2010","unstructured":"Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R (2010) Pre-eclampsia. Lancet 376:631\u2013644. https:\/\/doi.org\/10.1016\/S0140-6736(10)60279-6","journal-title":"Lancet"},{"key":"4648_CR2","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.preghy.2018.05.004","volume":"13","author":"MA Brown","year":"2018","unstructured":"Brown MA, Magee LA, Kenny LC et al (2018) The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens 13:291\u2013310. https:\/\/doi.org\/10.1016\/j.preghy.2018.05.004","journal-title":"Pregnancy Hypertens"},{"key":"4648_CR3","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1097\/AOG.0000000000003508","volume":"134","author":"EK Redman","year":"2019","unstructured":"Redman EK, Hauspurg A, Hubel CA et al (2019) Clinical course, associated factors, and blood pressure profile of delayed-onset postpartum preeclampsia. Obstet Gynecol 134:995\u20131001. https:\/\/doi.org\/10.1097\/AOG.0000000000003508","journal-title":"Obstet Gynecol"},{"key":"4648_CR4","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1056\/NEJMoa0707943","volume":"358","author":"BE Metzger","year":"2008","unstructured":"Metzger BE, Contreras M, Sacks DA et al (2008) Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 358:1991\u20132002. https:\/\/doi.org\/10.1056\/NEJMoa0707943","journal-title":"N Engl J Med"},{"key":"4648_CR5","doi-asserted-by":"publisher","first-page":"780","DOI":"10.2337\/dc11-1790","volume":"35","author":"PM Catalano","year":"2012","unstructured":"Catalano PM, McIntyre HD, Cruickshank JK et al (2012) The hyperglycemia and adverse pregnancy outcome study: associations of GDM and obesity with pregnancy outcomes. Diabetes Care 35:780\u2013786. https:\/\/doi.org\/10.2337\/dc11-1790","journal-title":"Diabetes Care"},{"key":"4648_CR6","doi-asserted-by":"publisher","first-page":"255.e1","DOI":"10.1016\/j.ajog.2010.01.024","volume":"202","author":"C Yogev","year":"2010","unstructured":"Yogev C, Hod C, Oats M, Metzger L, Dyer D, Trimble M, Hadden PR (2010) Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: preeclampsia. Am J Obstet Gynecol 202:255.e1-255.e7. https:\/\/doi.org\/10.1016\/j.ajog.2010.01.024","journal-title":"Am J Obstet Gynecol"},{"key":"4648_CR7","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/dme.13523","volume":"35","author":"A Alqudah","year":"2018","unstructured":"Alqudah A, McKinley MC, McNally R et al (2018) Risk of pre-eclampsia in women taking metformin: a systematic review and meta-analysis. Diabet Med 35:160\u2013172. https:\/\/doi.org\/10.1111\/dme.13523","journal-title":"Diabet Med"},{"key":"4648_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1242\/dmm.008516","volume":"5","author":"KA Pennington","year":"2012","unstructured":"Pennington KA, Schlitt JM, Jackson DL et al (2012) Preeclampsia: multiple approaches for a multifactorial disease. Dis Model Mech 5:9\u201318. https:\/\/doi.org\/10.1242\/dmm.008516","journal-title":"Dis Model Mech"},{"key":"4648_CR9","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.3389\/fimmu.2018.02597","volume":"9","author":"J Pollheimer","year":"2018","unstructured":"Pollheimer J, Vondra S, Baltayeva J et al (2018) Regulation of placental extravillous trophoblasts by the maternal uterine environment. Front Immunol 9:2597. https:\/\/doi.org\/10.3389\/fimmu.2018.02597","journal-title":"Front Immunol"},{"key":"4648_CR10","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/micc.12080","volume":"24","author":"G Osol","year":"2009","unstructured":"Osol G, Mandala M (2009) Maternal uterine vascular remodeling during pregnancy. Physiology 24:58\u201371. https:\/\/doi.org\/10.1111\/micc.12080","journal-title":"Physiology"},{"key":"4648_CR11","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.placenta.2009.02.009","volume":"30","author":"GJ Burton","year":"2009","unstructured":"Burton GJ, Woods AW, Jauniaux E, Kingdom JCP (2009) Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy. Placenta 30:473\u2013482. https:\/\/doi.org\/10.1016\/j.placenta.2009.02.009","journal-title":"Placenta"},{"key":"4648_CR12","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/S0002-9378(96)70407-6","volume":"174","author":"A Halim","year":"1996","unstructured":"Halim A, Kanayama N, El Maradny E et al (1996) Plasma P selectin (GMP-140) and glycocalicin are elevated in preeclampsia and eclampsia: their significances. Am J Obstet Gynecol 174:272\u2013277. https:\/\/doi.org\/10.1016\/S0002-9378(96)70407-6","journal-title":"Am J Obstet Gynecol"},{"key":"4648_CR13","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.1600-0897.1999.tb00442.x","volume":"41","author":"S Saito","year":"1999","unstructured":"Saito S, Umekage H, Sakamoto Y et al (1999) Increased T-helper-1-type immunity and decreased T-helper-2-type immunity in patients with preeclampsia. Am J Reprod Immunol 41:297\u2013306. https:\/\/doi.org\/10.1111\/j.1600-0897.1999.tb00442.x","journal-title":"Am J Reprod Immunol"},{"key":"4648_CR14","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/0002-9378(95)90113-2","volume":"172","author":"SA Friedman","year":"1995","unstructured":"Friedman SA, Schiff E, Emeis JJ et al (1995) Biochemical corroboration of endothelial involvement in severe preeclampsia. Am J Obstet Gynecol 172:202\u2013203. https:\/\/doi.org\/10.1016\/0002-9378(95)90113-2","journal-title":"Am J Obstet Gynecol"},{"key":"4648_CR15","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S0301-2115(00)00501-7","volume":"97","author":"D Islami","year":"2001","unstructured":"Islami D, Shoukir Y, Dupont P et al (2001) Is cellular fibronectin a biological marker for pre-eclampsia? Eur J Obstet Gynecol Reprod Biol 97:40\u201345. https:\/\/doi.org\/10.1016\/S0301-2115(00)00501-7","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"4648_CR16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/jmf.12.1.19.27","volume":"12","author":"T Chaiworapongsa","year":"2002","unstructured":"Chaiworapongsa T, Romero R, Yoshimatsu J et al (2002) Soluble adhesion molecule profile in normal pregnancy and pre-eclampsia. J Matern Neonatal Med Off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int Soc Perinat Obstet 12:19\u201327. https:\/\/doi.org\/10.1080\/jmf.12.1.19.27","journal-title":"J Matern Neonatal Med Off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int Soc Perinat Obstet"},{"key":"4648_CR17","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0301-2115(96)02647-4","volume":"71","author":"R Austgulen","year":"1997","unstructured":"Austgulen R, Lien E, Vince G, Redman CWG (1997) Increased maternal plasma levels of soluble adhesion molecules (ICAM-1, VCAM-1, E-selectin) in preeclampsia. Eur J Obstet Gynecol Reprod Biol 71:53\u201358. https:\/\/doi.org\/10.1016\/S0301-2115(96)02647-4","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"4648_CR18","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.tice.2018.09.002","volume":"54","author":"K Habas","year":"2018","unstructured":"Habas K, Shang L (2018) Alterations in intercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1) in human endothelial cells. Tissue Cell 54:139\u2013143. https:\/\/doi.org\/10.1016\/j.tice.2018.09.002","journal-title":"Tissue Cell"},{"key":"4648_CR19","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1160\/TH05-07-0527","volume":"95","author":"AD Blann","year":"2006","unstructured":"Blann AD (2006) Plasma von Willebrand factor, thrombosis, and the endothelium: the first 30 years. Thromb Haemost 95:49\u201355","journal-title":"Thromb Haemost"},{"key":"4648_CR20","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/sj.jhh.1001403","volume":"16","author":"Z Hlubock\u00e1","year":"2002","unstructured":"Hlubock\u00e1 Z, Umnerov\u00e1 V, Heller S et al (2002) Circulating intercellular cell adhesion molecule-1, endothelin-1 and von Willebrand factor-markers of endothelial dysfunction in uncomplicated essential hypertension: the effect of treatment with ACE inhibitors. J Hum Hypertens 16:557\u2013562. https:\/\/doi.org\/10.1038\/sj.jhh.1001403","journal-title":"J Hum Hypertens"},{"key":"4648_CR21","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1016\/S0002-9378(12)91845-1","volume":"170","author":"MJ Kupferminc","year":"1994","unstructured":"Kupferminc MJ, Peaceman AM, Wigton TR et al (1994) Tumor necrosis factor-\u03b1 is elevated in plasma and amniotic fluid of patients with severe preeclampsia. Am J Obstet Gynecol 170:1752\u20131759. https:\/\/doi.org\/10.1016\/S0002-9378(12)91845-1","journal-title":"Am J Obstet Gynecol"},{"key":"4648_CR22","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1210\/clinem\/dgaa403","volume":"106","author":"N Todd","year":"2021","unstructured":"Todd N, McNally R, Alqudah A et al (2021) Role of a novel angiogenesis FKBPL-CD44 pathway in preeclampsia risk stratification and mesenchymal stem cell treatment. J Clin Endocrinol Metab 106:26\u201341. https:\/\/doi.org\/10.1210\/clinem\/dgaa403","journal-title":"J Clin Endocrinol Metab"},{"key":"4648_CR23","doi-asserted-by":"publisher","DOI":"10.1080\/01443615.2021.1991293","author":"N Atakul","year":"2021","unstructured":"Atakul N, Atamer Y, Selek \u015e et al (2021) ST2 and galectin-3 as novel biomarkers for the prediction of future cardiovascular disease risk in preeclampsia. J Obstet Gynaecol (Lahore). https:\/\/doi.org\/10.1080\/01443615.2021.1991293","journal-title":"J Obstet Gynaecol (Lahore)"},{"key":"4648_CR24","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41416-019-0649-5","volume":"122","author":"S Annett","year":"2020","unstructured":"Annett S, Moore G, Short A et al (2020) FKBPL-based peptide, ALM201, targets angiogenesis and cancer stem cells in ovarian cancer. Br J Cancer 122:361\u2013371. https:\/\/doi.org\/10.1038\/s41416-019-0649-5","journal-title":"Br J Cancer"},{"key":"4648_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0055075","volume":"8","author":"A Yakkundi","year":"2013","unstructured":"Yakkundi A, McCallum L, O\u2019Kane A et al (2013) The anti-migratory effects of FKBPL and its peptide derivative, AD-01: regulation of CD44 and the cytoskeletal pathway. PLoS ONE 8:e55075. https:\/\/doi.org\/10.1371\/journal.pone.0055075","journal-title":"PLoS ONE"},{"key":"4648_CR26","doi-asserted-by":"publisher","first-page":"3881","DOI":"10.1158\/1078-0432.CCR-13-0595","volume":"19","author":"L McClements","year":"2013","unstructured":"McClements L, Yakkundi A, Papaspyropoulos A et al (2013) Targeting treatment-resistant breast cancer stem cells with FKBPL and its peptide derivative, AD-01, via the CD44 pathway. Clin Cancer Res 19:3881\u20133893. https:\/\/doi.org\/10.1158\/1078-0432.CCR-13-0595","journal-title":"Clin Cancer Res"},{"key":"4648_CR27","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1186\/s12885-019-5500-0","volume":"19","author":"L McClements","year":"2019","unstructured":"McClements L, Annett S, Yakkundi A et al (2019) FKBPL and its peptide derivatives inhibit endocrine therapy resistant cancer stem cells and breast cancer metastasis by downregulating DLL4 and Notch4. BMC Cancer 19:351. https:\/\/doi.org\/10.1186\/s12885-019-5500-0","journal-title":"BMC Cancer"},{"key":"4648_CR28","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1161\/ATVBAHA.114.304539","volume":"35","author":"A Yakkundi","year":"2015","unstructured":"Yakkundi A, Bennett R, Hern\u00e1ndez-Negrete I et al (2015) FKBPL is a critical antiangiogenic regulator of developmental and pathological angiogenesis. Arterioscler Thromb Vasc Biol 35:845\u2013854. https:\/\/doi.org\/10.1161\/ATVBAHA.114.304539","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4648_CR29","doi-asserted-by":"publisher","first-page":"5724","DOI":"10.1210\/en.2008-0168","volume":"149","author":"HD McKeen","year":"2008","unstructured":"McKeen HD, McAlpine K, Valentine A et al (2008) A novel FK506-like binding protein interacts with the glucocorticoid receptor and regulates steroid receptor signaling. Endocrinology 149:5724\u20135734. https:\/\/doi.org\/10.1210\/en.2008-0168","journal-title":"Endocrinology"},{"key":"4648_CR30","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1477-7827-8-22","volume":"8","author":"O Sunnotel","year":"2010","unstructured":"Sunnotel O, Hiripi L, Lagan K et al (2010) Alterations in the steroid hormone receptor co-chaperone FKBPL are associated with male infertility: a case-control study. Reprod Biol Endocrinol 8:22. https:\/\/doi.org\/10.1186\/1477-7827-8-22","journal-title":"Reprod Biol Endocrinol"},{"key":"4648_CR31","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1158\/1078-0432.CCR-10-2241","volume":"17","author":"A Valentine","year":"2011","unstructured":"Valentine A, O\u2019Rourke M, Yakkundi A et al (2011) FKBPL and peptide derivatives: novel biological agents that inhibit angiogenesis by a CD44-dependent mechanism. Clin Cancer Res 17:1044\u20131056. https:\/\/doi.org\/10.1158\/1078-0432.CCR-10-2241","journal-title":"Clin Cancer Res"},{"key":"4648_CR32","doi-asserted-by":"publisher","DOI":"10.1101\/2021.02.24.431422","author":"S Annett","year":"2021","unstructured":"Annett S, Spence S, Garciarena C et al (2021) The immunophilin protein FKBPL and its peptide derivatives are novel regulators of vascular integrity and inflammation via NF-\u03baB signaling. bioRxiv. https:\/\/doi.org\/10.1101\/2021.02.24.431422","journal-title":"bioRxiv"},{"key":"4648_CR33","doi-asserted-by":"publisher","first-page":"21655","DOI":"10.1038\/s41598-020-78676-6","volume":"10","author":"AS Januszewski","year":"2020","unstructured":"Januszewski AS, Watson CJ, O\u2019Neill V et al (2020) FKBPL is associated with metabolic parameters and is a novel determinant of cardiovascular disease. Sci Rep 10:21655. https:\/\/doi.org\/10.1038\/s41598-020-78676-6","journal-title":"Sci Rep"},{"key":"4648_CR34","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13293-021-00376-1","volume":"12","author":"C Richards","year":"2021","unstructured":"Richards C, Sesperez K, Chhor M et al (2021) (2021) Characterisation of cardiac health in the reduced uterine perfusion pressure model and a 3D cardiac spheroid model, of preeclampsia. Biol Sex Differ 12:31. https:\/\/doi.org\/10.1186\/s13293-021-00376-1","journal-title":"Biol Sex Differ"},{"key":"4648_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.650328","author":"A Alqudah","year":"2021","unstructured":"Alqudah A, Eastwood K-A, Jerotic D et al (2021) FKBPL and SIRT-1 are downregulated by diabetes in pregnancy impacting on angiogenesis and endothelial function. Front Endocrinol (Lausanne). https:\/\/doi.org\/10.3389\/fendo.2021.650328","journal-title":"Front Endocrinol (Lausanne)"},{"key":"4648_CR36","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1124\/jpet.114.218370","volume":"351","author":"LC Li","year":"2014","unstructured":"Li LC, Li J, Gao J (2014) Functions of galectin-3 and its role in fibrotic diseases. J Pharmacol Exp Ther 351:336\u2013343. https:\/\/doi.org\/10.1124\/jpet.114.218370","journal-title":"J Pharmacol Exp Ther"},{"key":"4648_CR37","doi-asserted-by":"publisher","first-page":"13145","DOI":"10.1038\/s41598-019-49511-4","volume":"9","author":"OM Andrejic","year":"2019","unstructured":"Andrejic OM, Vucic RM, Pavlovic M et al (2019) Association between Galectin-3 levels within central and peripheral venous blood, and adverse left ventricular remodelling after first acute myocardial infarction. Sci Rep 9:13145. https:\/\/doi.org\/10.1038\/s41598-019-49511-4","journal-title":"Sci Rep"},{"key":"4648_CR38","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.placenta.2004.03.006","volume":"25","author":"M Bozi\u0107","year":"2004","unstructured":"Bozi\u0107 M, Petronijevi\u0107 M, Milenkovi\u0107 S et al (2004) Galectin-1 and galectin-3 in the trophoblast of the gestational trophoblastic disease. Placenta 25:797\u2013802. https:\/\/doi.org\/10.1016\/j.placenta.2004.03.006","journal-title":"Placenta"},{"key":"4648_CR39","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1093\/humrep\/13.3.730","volume":"13","author":"L Vi\u0107ovac","year":"1998","unstructured":"Vi\u0107ovac L, Jankovi\u0107 M, Cuperlovi\u0107 M (1998) Galectin-1 and -3 in cells of the first trimester placental bed. Hum Reprod 13:730\u2013735. https:\/\/doi.org\/10.1093\/humrep\/13.3.730","journal-title":"Hum Reprod"},{"key":"4648_CR40","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.placenta.2007.06.006","volume":"28","author":"U Jeschke","year":"2007","unstructured":"Jeschke U, Mayr D, Schiessl B et al (2007) Expression of galectin-1, -3 (gal-1, gal-3) and the Thomsen-Friedenreich (TF) antigen in normal, IUGR, preeclamptic and HELLP placentas. Placenta 28:1165\u20131173. https:\/\/doi.org\/10.1016\/j.placenta.2007.06.006","journal-title":"Placenta"},{"key":"4648_CR41","doi-asserted-by":"publisher","first-page":"288","DOI":"10.2353\/ajpath.2008.070726","volume":"172","author":"NC Henderson","year":"2008","unstructured":"Henderson NC, Mackinnon AC, Farnworth SL et al (2008) Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis. Am J Pathol 172:288\u2013298. https:\/\/doi.org\/10.2353\/ajpath.2008.070726","journal-title":"Am J Pathol"},{"issue":"23","key":"4648_CR42","first-page":"8302","volume":"63","author":"T Fukumori","year":"2003","unstructured":"Fukumori T, Takenaka Y, Yoshii T et al (2003) CD29 and CD7 mediate galectin-3-induced type II T-cell apoptosis. Cancer Res. 63(23):8302\u20138311","journal-title":"Cancer Res."},{"key":"4648_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/259256","volume":"2013","author":"C Danella Polli","year":"2013","unstructured":"Danella Polli C, Alves Toledo K, Franco LH et al (2013) Monocyte migration driven by galectin-3 occurs through distinct mechanisms involving selective interactions with the extracellular matrix. ISRN Inflamm 2013:1\u20139. https:\/\/doi.org\/10.1155\/2013\/259256","journal-title":"ISRN Inflamm"},{"key":"4648_CR44","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1159\/000355846","volume":"51","author":"C Yabuta","year":"2014","unstructured":"Yabuta C, Yano F, Fujii A et al (2014) Galectin-3 enhances epithelial cell adhesion and wound healing in rat cornea. Ophthalmic Res 51:96\u2013103. https:\/\/doi.org\/10.1159\/000355846","journal-title":"Ophthalmic Res"},{"key":"4648_CR45","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.18632\/oncotarget.1786","volume":"5","author":"X Gao","year":"2014","unstructured":"Gao X, Balan B, Tai G, Raz A (2014) Galectin-3 induces cell migration via a calcium-sensitive MAPK\/ERK1\/2 pathway. Oncotarget 5:2077\u20132084. https:\/\/doi.org\/10.18632\/oncotarget.1786","journal-title":"Oncotarget"},{"key":"4648_CR46","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1006\/excr.1998.4253","volume":"245","author":"H Inohara","year":"1998","unstructured":"Inohara H, Akahani S, Raz A (1998) Galectin-3 stimulates cell proliferation. Exp Cell Res 245:294\u2013302. https:\/\/doi.org\/10.1006\/excr.1998.4253","journal-title":"Exp Cell Res"},{"key":"4648_CR47","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1016\/j.ajpath.2013.01.017","volume":"182","author":"W Jia","year":"2013","unstructured":"Jia W, Kidoya H, Yamakawa D et al (2013) Galectin-3 accelerates M2 macrophage infiltration and angiogenesis in tumors. Am J Pathol 182:1821\u20131831. https:\/\/doi.org\/10.1016\/j.ajpath.2013.01.017","journal-title":"Am J Pathol"},{"key":"4648_CR48","doi-asserted-by":"publisher","DOI":"10.26402\/jpp.2020.6.08","author":"K Pankiewicz","year":"2020","unstructured":"Pankiewicz K, Szczerba E, Fijalkowska A et al (2020) The association between serum galectin-3 level and its placental production in patients with preeclampsia. J Physiol Pharmacol an Off J Polish Physiol Soc. https:\/\/doi.org\/10.26402\/jpp.2020.6.08","journal-title":"J Physiol Pharmacol an Off J Polish Physiol Soc"},{"key":"4648_CR49","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1080\/10641955.2020.1777300","volume":"39","author":"AS Taha","year":"2020","unstructured":"Taha AS, Zahraei Z, Al-Hakeim HK (2020) Serum apelin and galectin-3 in preeclampsia in Iraq. Hypertens Pregnancy 39:379\u2013386. https:\/\/doi.org\/10.1080\/10641955.2020.1777300","journal-title":"Hypertens Pregnancy"},{"key":"4648_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.preghy.2020.03.011","author":"S Suvakov","year":"2020","unstructured":"Suvakov S, Bonner E, Nikolic V et al (2020) Overlapping pathogenic signalling pathways and biomarkers in preeclampsia and cardiovascular disease. Pregnancy Hypertens. https:\/\/doi.org\/10.1016\/j.preghy.2020.03.011","journal-title":"Pregnancy Hypertens"},{"key":"4648_CR51","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.rbmo.2013.08.002","volume":"27","author":"CHE Weimar","year":"2013","unstructured":"Weimar CHE, Post Uiterweer ED, Teklenburg G et al (2013) In-vitro model systems for the study of human embryo-endometrium interactions. Reprod Biomed Online 27:461\u2013476. https:\/\/doi.org\/10.1016\/j.rbmo.2013.08.002","journal-title":"Reprod Biomed Online"},{"key":"4648_CR52","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1016\/j.placenta.2010.11.023","volume":"32","author":"K Orendi","year":"2011","unstructured":"Orendi K, Kivity V, Sammar M et al (2011) Placental and trophoblastic in vitro models to study preventive and therapeutic agents for preeclampsia. Placenta 32:S49\u2013S54. https:\/\/doi.org\/10.1016\/j.placenta.2010.11.023","journal-title":"Placenta"},{"key":"4648_CR53","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1093\/humupd\/dmaa017","volume":"26","author":"Y Abbas","year":"2020","unstructured":"Abbas Y, Turco MY, Burton GJ, Moffett A (2020) Investigation of human trophoblast invasion in vitro. Hum Reprod Update 26:501\u2013513. https:\/\/doi.org\/10.1093\/humupd\/dmaa017","journal-title":"Hum Reprod Update"},{"key":"4648_CR54","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1053\/j.semperi.2007.11.004","volume":"32","author":"JS Barry","year":"2008","unstructured":"Barry JS, Rozance PJ, Anthony RV (2008) An animal model of placental insufficiency-induced intrauterine growth restriction. Semin Perinatol 32:225\u2013230. https:\/\/doi.org\/10.1053\/j.semperi.2007.11.004","journal-title":"Semin Perinatol"},{"key":"4648_CR55","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/1477-7827-9-105","volume":"9","author":"L Belkacemi","year":"2011","unstructured":"Belkacemi L, Jelks A, Chen C-H et al (2011) Altered placental development in undernourished rats: role of maternal glucocorticoids. Reprod Biol Endocrinol 9:105. https:\/\/doi.org\/10.1186\/1477-7827-9-105","journal-title":"Reprod Biol Endocrinol"},{"key":"4648_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.00715","author":"L Richardson","year":"2020","unstructured":"Richardson L, Kim S, Menon R, Han A (2020) Organ-on-chip technology: the future of feto-maternal interface research? Front Physiol. https:\/\/doi.org\/10.3389\/fphys.2020.00715","journal-title":"Front Physiol"},{"key":"4648_CR57","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.addr.2021.03.010","volume":"173","author":"RE Young","year":"2021","unstructured":"Young RE, Huh DD (2021) Organ-on-a-chip technology for the study of the female reproductive system. Adv Drug Deliv Rev 173:461\u2013478. https:\/\/doi.org\/10.1016\/j.addr.2021.03.010","journal-title":"Adv Drug Deliv Rev"},{"key":"4648_CR58","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/1471-213X-7-137","volume":"7","author":"U Hiden","year":"2007","unstructured":"Hiden U, Wadsack C, Prutsch N et al (2007) The first trimester human trophoblast cell line ACH-3P: a novel tool to study autocrine\/paracrine regulatory loops of human trophoblast subpopulations\u2014TNF-\u03b1 stimulates MMP15 expression. BMC Dev Biol 7:137. https:\/\/doi.org\/10.1186\/1471-213X-7-137","journal-title":"BMC Dev Biol"},{"key":"4648_CR59","doi-asserted-by":"publisher","unstructured":"(2019) ACOG Practice Bulletin No. 202: Gestational Hypertension and Preeclampsia. Obstet Gynecol 133:e1\u2013e25. https:\/\/doi.org\/10.1097\/AOG.0000000000003018","DOI":"10.1097\/AOG.0000000000003018"},{"key":"4648_CR60","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.preghy.2020.03.004","volume":"20","author":"N De Alwis","year":"2020","unstructured":"De Alwis N, Beard S, Mangwiro YT et al (2020) Pravastatin as the statin of choice for reducing pre-eclampsia-associated endothelial dysfunction. Pregnancy Hypertens 20:83\u201391. https:\/\/doi.org\/10.1016\/j.preghy.2020.03.004","journal-title":"Pregnancy Hypertens"},{"key":"4648_CR61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0188845","volume":"13","author":"TJ Kaitu\u2019u-Lino","year":"2018","unstructured":"Kaitu\u2019u-Lino TJ, Brownfoot FC, Beard S et al (2018) Combining metformin and esomeprazole is additive in reducing sFlt-1 secretion and decreasing endothelial dysfunction - implications for treating preeclampsia. PLoS ONE 13:e0188845. https:\/\/doi.org\/10.1371\/journal.pone.0188845","journal-title":"PLoS ONE"},{"key":"4648_CR62","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.placenta.2020.04.010","volume":"95","author":"FC Brownfoot","year":"2020","unstructured":"Brownfoot FC, Hastie R, Hannan NJ et al (2020) Combining metformin and sulfasalazine additively reduces the secretion of antiangiogenic factors from the placenta: Implications for the treatment of preeclampsia. Placenta 95:78\u201383. https:\/\/doi.org\/10.1016\/j.placenta.2020.04.010","journal-title":"Placenta"},{"key":"4648_CR63","unstructured":"AIM Biotech Gel Filling. https:\/\/aimbiotech.com\/2-gel-filling\/"},{"key":"4648_CR64","unstructured":"Nikon Ins (2020) Nikon introduces Clarify.ai for NIS-Elements, an artificial intelligence algorithm for removing blur from widefield microscope images. https:\/\/www.microscope.healthcare.nikon.com\/about\/news\/nikon-introduces-clarify-ai-for-nis-elements-an-artificial-intelligence-algorithm-for-removing-blur-from-widefield-microscope-images"},{"key":"4648_CR65","unstructured":"Carpentier G (2012) Angiogenesis Analyzer for ImageJ. http:\/\/image.bio.methods.free.fr\/ImageJ\/?Angiogenesis-Analyzer-for-ImageJ"},{"key":"4648_CR66","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/j.1600-065X.2009.00794.x","volume":"230","author":"NC Henderson","year":"2009","unstructured":"Henderson NC, Sethi T (2009) The regulation of inflammation by galectin-3. Immunol Rev 230:160\u2013171. https:\/\/doi.org\/10.1111\/j.1600-065X.2009.00794.x","journal-title":"Immunol Rev"},{"key":"4648_CR67","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.ajpath.2017.11.008","volume":"188","author":"T Ohmaru-Nakanishi","year":"2018","unstructured":"Ohmaru-Nakanishi T, Asanoma K, Fujikawa M et al (2018) Fibrosis in preeclamptic placentas is associated with stromal fibroblasts activated by the transforming growth factor-B1 signaling pathway. Am J Pathol 188:683\u2013695. https:\/\/doi.org\/10.1016\/j.ajpath.2017.11.008","journal-title":"Am J Pathol"},{"key":"4648_CR68","doi-asserted-by":"publisher","DOI":"10.1111\/aji.13311","volume":"84","author":"N Freitag","year":"2020","unstructured":"Freitag N, Tirado-Gonz\u00e1lez I, Barrientos G et al (2020) The chimera-type galectin-3 is a positive modulator of trophoblast functions with dysregulated expression in gestational diabetes mellitus. Am J Reprod Immunol 84:e13311. https:\/\/doi.org\/10.1111\/aji.13311","journal-title":"Am J Reprod Immunol"},{"key":"4648_CR69","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1038\/s41598-018-38374-w","volume":"9","author":"\u017d Boji\u0107-Trbojevi\u0107","year":"2019","unstructured":"Boji\u0107-Trbojevi\u0107 \u017d, Jovanovi\u0107 Krivoku\u0107a M, Viloti\u0107 A et al (2019) Human trophoblast requires galectin-3 for cell migration and invasion. Sci Rep 9:2136. https:\/\/doi.org\/10.1038\/s41598-018-38374-w","journal-title":"Sci Rep"},{"key":"4648_CR70","first-page":"886","volume":"6","author":"LP Reynolds","year":"1992","unstructured":"Reynolds LP, Killilea SD, Redmer DA (1992) Angiogenesis in the female reproductive system. FASEB J Off Publ Fed Am Soc Exp Biol 6:886\u2013892","journal-title":"FASEB J Off Publ Fed Am Soc Exp Biol"},{"key":"4648_CR71","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/s0143-4004(97)80044-6","volume":"18","author":"E Maquoi","year":"1997","unstructured":"Maquoi E, van den Br\u00fble FA, Castronovo V, Foidart JM (1997) Changes in the distribution pattern of galectin-1 and galectin-3 in human placenta correlates with the differentiation pathways of trophoblasts. Placenta 18:433\u2013439. https:\/\/doi.org\/10.1016\/s0143-4004(97)80044-6","journal-title":"Placenta"},{"key":"4648_CR72","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1365-2796.2011.02476.x","volume":"272","author":"RA De Boer","year":"2012","unstructured":"De Boer RA, van Veldhuisen DJ, Gansevoort RT et al (2012) The fibrosis marker galectin-3 and outcome in the general population. J Intern Med 272:55\u201364. https:\/\/doi.org\/10.1111\/j.1365-2796.2011.02476.x","journal-title":"J Intern Med"},{"key":"4648_CR73","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.1016\/j.ijcard.2013.12.129","volume":"172","author":"J Sanchez-Mas","year":"2014","unstructured":"Sanchez-Mas J, Lax A, Asensio-Lopez MC et al (2014) Galectin-3 expression in cardiac remodeling after myocardial infarction. Int J Cardiol 172:e98\u2013e101. https:\/\/doi.org\/10.1016\/j.ijcard.2013.12.129","journal-title":"Int J Cardiol"},{"key":"4648_CR74","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/j.1365-2249.2011.04509.x","volume":"167","author":"M Demmert","year":"2012","unstructured":"Demmert M, Faust K, Bohlmann MK et al (2012) Galectin-3 in cord blood of term and preterm infants. Clin Exp Immunol 167:246\u2013251. https:\/\/doi.org\/10.1111\/j.1365-2249.2011.04509.x","journal-title":"Clin Exp Immunol"},{"key":"4648_CR75","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s41419-020-02791-5","volume":"11","author":"N Freitag","year":"2020","unstructured":"Freitag N, Tirado-Gonzalez I, Barrientos G et al (2020) Galectin-3 deficiency in pregnancy increases the risk of fetal growth restriction (FGR) via placental insufficiency. Cell Death Dis 11:560. https:\/\/doi.org\/10.1038\/s41419-020-02791-5","journal-title":"Cell Death Dis"},{"key":"4648_CR76","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3892\/mmr.2016.6020","volume":"15","author":"M Hao","year":"2017","unstructured":"Hao M, Li M, Li W (2017) Galectin-3 inhibition ameliorates hypoxia-induced pulmonary artery hypertension. Mol Med Rep 15:160\u2013168. https:\/\/doi.org\/10.3892\/mmr.2016.6020","journal-title":"Mol Med Rep"},{"key":"4648_CR77","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/art.30118","volume":"63","author":"H Forsman","year":"2011","unstructured":"Forsman H, Islander U, Andr\u00e9asson E et al (2011) Galectin 3 aggravates joint inflammation and destruction in antigen-induced arthritis. Arthritis Rheum 63:445\u2013454. https:\/\/doi.org\/10.1002\/art.30118","journal-title":"Arthritis Rheum"},{"key":"4648_CR78","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1002\/hep.25542","volume":"55","author":"V Volarevic","year":"2012","unstructured":"Volarevic V, Milovanovic M, Ljujic B et al (2012) Galectin-3 deficiency prevents concanavalin A-induced hepatitis in mice. Hepatology 55:1954\u20131964. https:\/\/doi.org\/10.1002\/hep.25542","journal-title":"Hepatology"},{"key":"4648_CR79","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1038\/s41598-018-21072-y","volume":"8","author":"M Miyauchi","year":"2018","unstructured":"Miyauchi M, Ao M, Furusho H et al (2018) Galectin-3 plays an important role in preterm birth caused by dental infection of Porphyromonas gingivalis. Sci Rep 8:2867. https:\/\/doi.org\/10.1038\/s41598-018-21072-y","journal-title":"Sci Rep"},{"key":"4648_CR80","doi-asserted-by":"publisher","first-page":"8352","DOI":"10.1002\/jcp.27729","volume":"234","author":"R Mittal","year":"2019","unstructured":"Mittal R, Woo FW, Castro CS et al (2019) Organ-on-chip models: implications in drug discovery and clinical applications. J Cell Physiol 234:8352\u20138380. https:\/\/doi.org\/10.1002\/jcp.27729","journal-title":"J Cell Physiol"},{"key":"4648_CR81","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.3109\/14767058.2015.1038518","volume":"29","author":"JS Lee","year":"2016","unstructured":"Lee JS, Romero R, Han YM et al (2016) Placenta-on-a-chip: a novel platform to study the biology of the human placenta. J Matern neonatal Med Off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int Soc Perinat Obstet 29:1046\u20131054. https:\/\/doi.org\/10.3109\/14767058.2015.1038518","journal-title":"J Matern neonatal Med Off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int Soc Perinat Obstet"},{"key":"4648_CR82","doi-asserted-by":"publisher","DOI":"10.1098\/rsif.2017.0131","author":"Y Abbas","year":"2017","unstructured":"Abbas Y, Oefner CM, Polacheck WJ et al (2017) A microfluidics assay to study invasion of human placental trophoblast cells. J R Soc Interface. https:\/\/doi.org\/10.1098\/rsif.2017.0131","journal-title":"J R Soc Interface"},{"key":"4648_CR83","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1093\/biolre\/ioaa158","volume":"103","author":"Z Wang","year":"2020","unstructured":"Wang Z, Zibrila AI, Liu S et al (2020) Acetylcholine ameliorated TNF-\u03b1-induced primary trophoblast malfunction via muscarinic receptors\u2020. Biol Reprod 103:1238\u20131248. https:\/\/doi.org\/10.1093\/biolre\/ioaa158","journal-title":"Biol Reprod"},{"key":"4648_CR84","doi-asserted-by":"publisher","first-page":"4558","DOI":"10.1038\/s41598-017-04468-0","volume":"7","author":"T Cronqvist","year":"2017","unstructured":"Cronqvist T, Tannetta D, M\u00f6rgelin M et al (2017) Syncytiotrophoblast derived extracellular vesicles transfer functional placental miRNAs to primary human endothelial cells. Sci Rep 7:4558. https:\/\/doi.org\/10.1038\/s41598-017-04468-0","journal-title":"Sci Rep"},{"key":"4648_CR85","doi-asserted-by":"publisher","first-page":"5949","DOI":"10.4049\/jimmunol.178.9.5949","volume":"178","author":"SJ Germain","year":"2007","unstructured":"Germain SJ, Sacks GP, Sooranna SR et al (2007) Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotrophoblast microparticles. J Immunol 178:5949\u20135956. https:\/\/doi.org\/10.4049\/jimmunol.178.9.5949","journal-title":"J Immunol"},{"key":"4648_CR86","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1161\/01.ATV.0000148547.70187.89","volume":"25","author":"SV Ashton","year":"2005","unstructured":"Ashton SV, Whitley GSJ, Dash PR et al (2005) Uterine spiral artery remodeling involves endothelial apoptosis induced by extravillous trophoblasts through Fas\/FasL interactions. Arterioscler Thromb Vasc Biol 25:102\u2013108. https:\/\/doi.org\/10.1161\/01.ATV.0000148547.70187.89","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4648_CR87","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1093\/glycob\/cwu086","volume":"24","author":"T Funasaka","year":"2014","unstructured":"Funasaka T, Raz A, Nangia-Makker P (2014) Galectin-3 in angiogenesis and metastasis. Glycobiology 24:886\u2013891. https:\/\/doi.org\/10.1093\/glycob\/cwu086","journal-title":"Glycobiology"},{"key":"4648_CR88","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3892\/ijmm.2017.3311","volume":"41","author":"R Dong","year":"2018","unstructured":"Dong R, Zhang M, Hu Q et al (2018) Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy (review). Int J Mol Med 41:599\u2013614. https:\/\/doi.org\/10.3892\/ijmm.2017.3311","journal-title":"Int J Mol Med"},{"key":"4648_CR89","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1158\/0008-5472.CAN-15-1325","volume":"76","author":"MB Chen","year":"2016","unstructured":"Chen MB, Lamar JM, Li R et al (2016) Elucidation of the roles of tumor integrin \u03b21 in the extravasation stage of the metastasis cascade. Cancer Res 76:2513\u20132524. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-1325","journal-title":"Cancer Res"},{"key":"4648_CR90","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1089\/ten.TEC.2013.0370","volume":"20","author":"JA Whisler","year":"2014","unstructured":"Whisler JA, Chen MB, Kamm RD (2014) Control of perfusable microvascular network morphology using a multiculture microfluidic system. Tissue Eng Part C Methods 20:543\u2013552. https:\/\/doi.org\/10.1089\/ten.TEC.2013.0370","journal-title":"Tissue Eng Part C Methods"},{"key":"4648_CR91","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s12195-013-0315-6","volume":"7","author":"YK Park","year":"2014","unstructured":"Park YK, Tu T-Y, Lim SH et al (2014) In vitro microvessel growth and remodeling within a three-dimensional microfluidic environment. Cell Mol Bioeng 7:15\u201325. https:\/\/doi.org\/10.1007\/s12195-013-0315-6","journal-title":"Cell Mol Bioeng"},{"key":"4648_CR92","doi-asserted-by":"publisher","first-page":"1801531","DOI":"10.1002\/advs.201801531","volume":"6","author":"Y Xiao","year":"2019","unstructured":"Xiao Y, Kim D, Dura B et al (2019) Ex vivo dynamics of human glioblastoma cells in a microvasculature-on-a-chip system correlates with tumor heterogeneity and subtypes. Adv Sci 6:1801531. https:\/\/doi.org\/10.1002\/advs.201801531","journal-title":"Adv Sci"},{"key":"4648_CR93","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/MOH.0000000000000239","volume":"23","author":"P Lertkiatmongkol","year":"2016","unstructured":"Lertkiatmongkol P, Liao D, Mei H et al (2016) Endothelial functions of platelet\/endothelial cell adhesion molecule-1 (CD31). Curr Opin Hematol 23:253\u2013259. https:\/\/doi.org\/10.1097\/MOH.0000000000000239","journal-title":"Curr Opin Hematol"},{"key":"4648_CR94","first-page":"447","volume":"138","author":"B Robaye","year":"1991","unstructured":"Robaye B, Mosselmans R, Fiers W et al (1991) Tumor necrosis factor induces apoptosis (programmed cell death) in normal endothelial cells in vitro. Am J Pathol 138:447\u2013453","journal-title":"Am J Pathol"},{"key":"4648_CR95","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1111\/j.1538-7836.2005.01378.x","volume":"3","author":"RK Winn","year":"2005","unstructured":"Winn RK, Harlan JM (2005) The role of endothelial cell apoptosis in inflammatory and immune diseases. J Thromb Haemost 3:1815\u20131824. https:\/\/doi.org\/10.1111\/j.1538-7836.2005.01378.x","journal-title":"J Thromb Haemost"},{"key":"4648_CR96","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/bit.26850","volume":"116","author":"C-Y Kuo","year":"2019","unstructured":"Kuo C-Y, Shevchuk M, Opfermann J et al (2019) Trophoblast-endothelium signaling involves angiogenesis and apoptosis in a dynamic bioprinted placenta model. Biotechnol Bioeng 116:181\u2013192. https:\/\/doi.org\/10.1002\/bit.26850","journal-title":"Biotechnol Bioeng"},{"key":"4648_CR97","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.placenta.2014.12.013","volume":"36","author":"H Liu","year":"2015","unstructured":"Liu H, Li Y, Zhang J et al (2015) The defect of both angiogenesis and lymphangiogenesis is involved in preeclampsia. Placenta 36:279\u2013286. https:\/\/doi.org\/10.1016\/j.placenta.2014.12.013","journal-title":"Placenta"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-022-04648-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-022-04648-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-022-04648-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T00:09:40Z","timestamp":1678406980000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-022-04648-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,18]]},"references-count":97,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["4648"],"URL":"https:\/\/doi.org\/10.1007\/s00018-022-04648-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1606096\/v1","asserted-by":"object"}]},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,18]]},"assertion":[{"value":"28 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2023","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The funding note has been updated.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no financial conflict of interest. LM is an inventor on FKBPL-related patents.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval for this project was obtained from the University of Technology Sydney (UTS) Human Research Ethics Executive Review Committee and local hospital ethics committees. The study was conducted with the informed consent of each participant.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"All the authors have consented for the publication in the CMLS.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"44"}}